Prerna Tewari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Prerna Tewari has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Sharon O’ Toole
Trinity College Dublin, Dublin, Ireland
4 shared publications - Anthony Staines
Affiliation Centre eIntegrated Care (CeIC), Dublin City University, Dublin, Ireland
3 shared publications - Cara Martin
Discipline of Histopathology, School of Medicine, Trinity Translational Medicine Institute (TTMI), Trinity College Dublin, D02 PN40 Dublin, Ireland
3 shared publications - John James O'LEary
Trinity College Dublin
3 shared publications - Paul V. Browne
Department of Haematology, St. James's Hospital, Dublin, Ireland
3 shared publications - Abdul L. Shakerdi
Department of Surgery, Trinity Translational Medicine Institute, St James’s Hospital & Trinity College Dublin, D08 NHY1 Dublin, Ireland
2 shared publications
Latest Publications
- Open Access
Crosstalk Between Inflammasome Signalling and Epithelial-Mesenchymal Transition in Cancer and Benign Disease: Mechanistic Insights, Context-Dependence, and Therapeutic Opportunities
Epithelial-mesenchymal transition (EMT) and inflammasome signalling are intercon-nected processes which underpin tumour progression, metastasis, and therapeutic re-sistance. Inflammasomes such as NLRP3 encourage pro-inflammatory states (IL-1β, IL-18, NF-κB) and the activation of signalling pathways like TGF-β that promote mes-enchymal traits crucial for EMT. EMT transcriptional programmes can then in turn modulate the inflammasome via NF-κB/TGF-β signalling, creating self-perpetuating mechanisms of cellular plasticity and dysregulated therapeutic response. We have re-viewed the mechanistic evidence for EMT–inflammasome crosstalk in cancer and discussed the potential therapeutic implications. The function of the EMT-inflammasome axis is clearly context-dependent, with the cancer type, stage, and the complexity of the tumour microenvironment heavily contributing. The crosstalk between EMT and the inflammasome is an overlooked mechanism of tumour evolution, and targeting inflammasomes like NLRP3, or their downstream signalling pathways, offers a promising therapeutic avenue, with the objective of inhibiting metastasis and overcoming drug resistance.
Open AccessCrosstalk Between Inflammasome Signalling and Epithelial-Mesenchymal Transition in Cancer and Benign Disease: Mechanistic Insights, Context-Dependence, and Therapeutic Opportunities
Epithelial-mesenchymal transition (EMT) and inflammasome signalling are intercon-nected processes which underpin tumour progression, metastasis, and therapeutic re-sistance. Inflammasomes such as NLRP3 encourage pro-inflammatory states (IL-1β, IL-18, NF-κB) and the activation of signalling pathways like TGF-β that promote mes-enchymal traits crucial for EMT. EMT transcriptional programmes can then in turn modulate the inflammasome via NF-κB/TGF-β signalling, creating self-perpetuating mechanisms of cellular plasticity and dysregulated therapeutic response. We have re-viewed the mechanistic evidence for EMT–inflammasome crosstalk in cancer and discussed the potential therapeutic implications. The function of the EMT-inflammasome axis is clearly context-dependent, with the cancer type, stage, and the complexity of the tumour microenvironment heavily contributing. The crosstalk between EMT and the inflammasome is an overlooked mechanism of tumour evolution, and targeting inflammasomes like NLRP3, or their downstream signalling pathways, offers a promising therapeutic avenue, with the objective of inhibiting metastasis and overcoming drug resistance.
- Open Access
- 12 September 2025
- Published by MDPI AG in Preprints.org
Crosstalk Between Inflammasome Signalling and Epithelial-Mesenchymal Transition in Cancer: Mechanistic Insights, Context-Dependence, and Therapeutic Opportunities
Epithelial-mesenchymal transition (EMT) and inflammasome signaling are interconnected processes which underpin tumour progression, metastasis, and therapeutic resistance. Inflammasomes such as NLRP3 encourage pro-inflammatory states (IL-1β, IL-18, NF-κB) and the activation of signalling pathways like TGF-β that promote mesenchymal traits crucial for EMT. EMT transcriptional programs can then in turn modulate the inflammasome via NF-κB/TGF-β signaling, creating self-perpetuating mechanisms of cellular plasticity and dysregulated therapeutic response. We have reviewed the mechanistic evidence for EMT–inflammasome crosstalk in cancer and discussed the potential therapeutic implications. The function of the ENT-inflammasome axis is clearly context-dependent, with the cancer type, stage, and the complexity of the tumour microenvironment heavily contributing. The between EMT and the inflammasome is an overlooked mechanism of tumour evolution and targeting inflammasomes like NLRP3, or their downstream signalling pathways offer a promising therapeutic avenue, with the therapeutic objective of reducing metastasis and overcoming drug resistance.
- 12 September 2025
- Published by MDPI AG in Preprints.org
Open AccessCrosstalk Between Inflammasome Signalling and Epithelial-Mesenchymal Transition in Cancer: Mechanistic Insights, Context-Dependence, and Therapeutic Opportunities
Epithelial-mesenchymal transition (EMT) and inflammasome signaling are interconnected processes which underpin tumour progression, metastasis, and therapeutic resistance. Inflammasomes such as NLRP3 encourage pro-inflammatory states (IL-1β, IL-18, NF-κB) and the activation of signalling pathways like TGF-β that promote mesenchymal traits crucial for EMT. EMT transcriptional programs can then in turn modulate the inflammasome via NF-κB/TGF-β signaling, creating self-perpetuating mechanisms of cellular plasticity and dysregulated therapeutic response. We have reviewed the mechanistic evidence for EMT–inflammasome crosstalk in cancer and discussed the potential therapeutic implications. The function of the ENT-inflammasome axis is clearly context-dependent, with the cancer type, stage, and the complexity of the tumour microenvironment heavily contributing. The between EMT and the inflammasome is an overlooked mechanism of tumour evolution and targeting inflammasomes like NLRP3, or their downstream signalling pathways offer a promising therapeutic avenue, with the therapeutic objective of reducing metastasis and overcoming drug resistance.
- Open Access
- 20 August 2021
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 17 (8) , e1009289
Estimating the conditional probability of developing human papilloma virus related oropharyngeal cancer by combining machine learning and inverse Bayesian modelling
The epidemic increase in the incidence of Human Papilloma Virus (HPV) related Oropharyngeal Squamous Cell Carcinomas (OPSCCs) in several countries worldwide represents a significant public health concern. Although gender neutral HPV vaccination programmes are expected to cause a reduction in the incidence rates of OPSCCs, these effects will not be evident in the foreseeable future. Secondary prevention strategies are currently not feasible due to an incomplete understanding of the natural history of oral HPV infections in OPSCCs. The key parameters that govern natural history models remain largely ill-defined for HPV related OPSCCs and cannot be easily inferred from experimental data. Mathematical models have been used to estimate some of these ill-defined parameters in cervical cancer, another HPV related cancer leading to successful implementation of cancer prevention strategies. We outline a “double-Bayesian” mathematical modelling approach, whereby, a Bayesian machine learning model first estimates the probability of an individual having an oral HPV infection, given OPSCC and other covariate information. The model is then inverted using Bayes’ theorem to reverse the probability relationship. We use data from the Surveillance, Epidemiology, and End Results (SEER) cancer registry, SEER Head and Neck with HPV Database and the National Health and Nutrition Examination Surveys (NHANES), representing the adult population in the United States to derive our model. The model contains 8,106 OPSCC patients of which 73.0% had an oral HPV infection. When stratified by age, sex, marital status and race/ethnicity, the model estimated a higher conditional probability for developing OPSCCs given an oral HPV infection in non-Hispanic White males and females compared to other races/ethnicities. The proposed Bayesian model represents a proof-of-concept of a natural history model of HPV driven OPSCCs and outlines a strategy for estimating the conditional probability of an individual’s risk of developing OPSCC following an oral HPV infection.
- 20 August 2021
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 17 (8) , e1009289
Open AccessEstimating the conditional probability of developing human papilloma virus related oropharyngeal cancer by combining machine learning and inverse Bayesian modelling
The epidemic increase in the incidence of Human Papilloma Virus (HPV) related Oropharyngeal Squamous Cell Carcinomas (OPSCCs) in several countries worldwide represents a significant public health concern. Although gender neutral HPV vaccination programmes are expected to cause a reduction in the incidence rates of OPSCCs, these effects will not be evident in the foreseeable future. Secondary prevention strategies are currently not feasible due to an incomplete understanding of the natural history of oral HPV infections in OPSCCs. The key parameters that govern natural history models remain largely ill-defined for HPV related OPSCCs and cannot be easily inferred from experimental data. Mathematical models have been used to estimate some of these ill-defined parameters in cervical cancer, another HPV related cancer leading to successful implementation of cancer prevention strategies. We outline a “double-Bayesian” mathematical modelling approach, whereby, a Bayesian machine learning model first estimates the probability of an individual having an oral HPV infection, given OPSCC and other covariate information. The model is then inverted using Bayes’ theorem to reverse the probability relationship. We use data from the Surveillance, Epidemiology, and End Results (SEER) cancer registry, SEER Head and Neck with HPV Database and the National Health and Nutrition Examination Surveys (NHANES), representing the adult population in the United States to derive our model. The model contains 8,106 OPSCC patients of which 73.0% had an oral HPV infection. When stratified by age, sex, marital status and race/ethnicity, the model estimated a higher conditional probability for developing OPSCCs given an oral HPV infection in non-Hispanic White males and females compared to other races/ethnicities. The proposed Bayesian model represents a proof-of-concept of a natural history model of HPV driven OPSCCs and outlines a strategy for estimating the conditional probability of an individual’s risk of developing OPSCC following an oral HPV infection.
- Open Access
- 18 March 2021
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 50 (7) , 692-699
Prevalence and concordance of oral HPV infections with cervical HPV infections in women referred to colposcopy with abnormal cytology
Background: Considering the shared aetiology of Human Papillomavirus infections in oropharyngeal and cervical cancers and the possible role for sexual transmission, several key aspects of the relationship between cervical and oral infections merit investigation, including prevalence of concomitant oral HPV infection and type‐specific concordance with concurrent cervical infections.Methods: A cross‐section study was performed on women referred to colposcopy clinics with cytological abnormalities and a cervical HPV infection. An oral rinse sample was taken from the participants at their baseline visit for HPV testing, and a demographic and risk factor questionnaire was also administered. HPV DNA testing was carried out on the Cobas 4800 platform and extended genotyping was carried out with the INNO‐LiPA HPV Genotyping Extra II assay. HPV genotyping was also carried out on the concurrent cervical tissue samples on all women who had a positive oral HPV infection.Results: The prevalence of oral HPV infections was 10.0% (95%CI:5.9–13.7) in the study population. HPV18 was the most frequent genotype (7.0%). Concordant oral and cervical HPV infections were detected in 28.6% of women. Age (p = 0.005) and level of education (p = 0.02) were significantly associated with a prevalent oral HPV infection.Conclusion: Concomitant oral HPV infections were present in 10.0% of women referred to colposcopy with a pre‐existing cervical HPV infections and cytological abnormalities. Although mild type‐specific concordance was observed between oral and cervical HPV infections, findings suggest that infections at these sites may not be independent of each other.
- 18 March 2021
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 50 (7) , 692-699
Open AccessPrevalence and concordance of oral HPV infections with cervical HPV infections in women referred to colposcopy with abnormal cytology
Background: Considering the shared aetiology of Human Papillomavirus infections in oropharyngeal and cervical cancers and the possible role for sexual transmission, several key aspects of the relationship between cervical and oral infections merit investigation, including prevalence of concomitant oral HPV infection and type‐specific concordance with concurrent cervical infections.Methods: A cross‐section study was performed on women referred to colposcopy clinics with cytological abnormalities and a cervical HPV infection. An oral rinse sample was taken from the participants at their baseline visit for HPV testing, and a demographic and risk factor questionnaire was also administered. HPV DNA testing was carried out on the Cobas 4800 platform and extended genotyping was carried out with the INNO‐LiPA HPV Genotyping Extra II assay. HPV genotyping was also carried out on the concurrent cervical tissue samples on all women who had a positive oral HPV infection.Results: The prevalence of oral HPV infections was 10.0% (95%CI:5.9–13.7) in the study population. HPV18 was the most frequent genotype (7.0%). Concordant oral and cervical HPV infections were detected in 28.6% of women. Age (p = 0.005) and level of education (p = 0.02) were significantly associated with a prevalent oral HPV infection.Conclusion: Concomitant oral HPV infections were present in 10.0% of women referred to colposcopy with a pre‐existing cervical HPV infections and cytological abnormalities. Although mild type‐specific concordance was observed between oral and cervical HPV infections, findings suggest that infections at these sites may not be independent of each other.
- Open Access
- 5 June 2020
- Published by Springer Nature in Research Square
Combining Machine Learning with Bayesian Inverse Modelling to Estimate the Conditional Probability of Developing Oropharyngeal Cancer following an Oral Human Papilloma Virus Infection
Background Despite an epidemic increase in the prevalence of Human Papilloma Virus (HPV) related Oropharyngeal Squamous Cell Carcinomas (OPSCCs) in Northern America and parts of Europe, there is virtually no information about the natural history of these cancers. The lack of well–defined precursor lesions and limited data on oral HPV persistence and clearance rates, poses a challenge for disease modelling. We propose a novel mathematical modelling approach to estimate the conditional probability of developing HPV related OPSCCs following a prevalent HPV infection and other covariates. Methods We developed a double-Bayes method, whereby a Bayesian machine learning model first estimates the probability of an individual having an oral HPV infection, given OPSCC and other covariate information. The model is then inverted using Bayes’ theorem to reverse the probability relationship. The mathematical model was derived from two datasets representing the adult population in the United States (US), the Surveillance Epidemiology and End Results Program (SEER) Head and Neck with HPV Status Database and the National Health and Nutrition Examination Survey (NHANES) 2011-2014. Results The model dataset contains 8,623 subjects of which 70.7% had a prevalent oral HPV positive infection. When stratified by age, sex, marital status and race/ethnicity, the model estimated higher conditional probability for developing OPSCCs following an oral HPV infection in non-Hispanic White males and females compared to other race/ethnicities. Non-Hispanic White males with an oral HPV infection had nearly two fold higher risk of developing OPSCC than non-Hispanic White females (10.6 cases per 10,000 thousand vs 5.05 cases per 10,000) in the age range 50-60. Conclusion We have employed a novel statistical approach to estimate the conditional probability of developing OPSCCs following an oral HPV infection and covariates age, sex, ethnicity and marital status in the US population. We recognise that at best this is a first guess estimate of a natural history model of HPV driven OPSCCs within the existing limitations of the model.
- 5 June 2020
- Published by Springer Nature in Research Square
Open AccessCombining Machine Learning with Bayesian Inverse Modelling to Estimate the Conditional Probability of Developing Oropharyngeal Cancer following an Oral Human Papilloma Virus Infection
Background Despite an epidemic increase in the prevalence of Human Papilloma Virus (HPV) related Oropharyngeal Squamous Cell Carcinomas (OPSCCs) in Northern America and parts of Europe, there is virtually no information about the natural history of these cancers. The lack of well–defined precursor lesions and limited data on oral HPV persistence and clearance rates, poses a challenge for disease modelling. We propose a novel mathematical modelling approach to estimate the conditional probability of developing HPV related OPSCCs following a prevalent HPV infection and other covariates. Methods We developed a double-Bayes method, whereby a Bayesian machine learning model first estimates the probability of an individual having an oral HPV infection, given OPSCC and other covariate information. The model is then inverted using Bayes’ theorem to reverse the probability relationship. The mathematical model was derived from two datasets representing the adult population in the United States (US), the Surveillance Epidemiology and End Results Program (SEER) Head and Neck with HPV Status Database and the National Health and Nutrition Examination Survey (NHANES) 2011-2014. Results The model dataset contains 8,623 subjects of which 70.7% had a prevalent oral HPV positive infection. When stratified by age, sex, marital status and race/ethnicity, the model estimated higher conditional probability for developing OPSCCs following an oral HPV infection in non-Hispanic White males and females compared to other race/ethnicities. Non-Hispanic White males with an oral HPV infection had nearly two fold higher risk of developing OPSCC than non-Hispanic White females (10.6 cases per 10,000 thousand vs 5.05 cases per 10,000) in the age range 50-60. Conclusion We have employed a novel statistical approach to estimate the conditional probability of developing OPSCCs following an oral HPV infection and covariates age, sex, ethnicity and marital status in the US population. We recognise that at best this is a first guess estimate of a natural history model of HPV driven OPSCCs within the existing limitations of the model.
- 3 October 2018
- Published by Wiley in Diagnostic Cytopathology
- Vol. 46 (12) , 987-992
Clinical performance of the Cobas 4800 HPV test and the Aptima HPV assay in the management of women referred to colposcopy with minor cytological abnormalities
Background: The aim of this study was to evaluate the clinical performance of the Cobas 4800 HPV test and the Aptima HPV assay for the detection of CIN2+ disease in women referred to colposcopy with minor cytological abnormalities.Methods: ThinPrep liquid‐based cytology samples were collected from 562 women referred to colposcopy with minor cytological abnormalities. HPV testing by both assays was performed on these samples. Clinical performances for detection of histologically diagnosed CIN2+ and CIN3+ were calculated.Results: HPV prevalence by the Cobas 4800 HPV test was 58.2% and 53.0% women tested positive with the Aptima HPV assay in the entire study population. The Aptima HPV assay and the Cobas 4800 HPV test displayed equivalent sensitivity of 90.2% (95%CI, 83.4‐94.9) for the detection of CIN2+ disease. However, the Aptima HPV assay displayed greater specificity of 61.0% (95% CI, 54.0‐68.0) when compared to the Cobas 4800 HPV test 53.0% (95% CI, 46.0‐60.0), and this was significantly higher (P = .0004). The Aptima HPV assay also displayed higher specificity 76.5% (95% CI, 66.0‐85.0) in the ASCUS category in comparison to the Cobas 4800 HPV test 65.0% (95% 54.0‐75.0) which was statistically significant (P = .004).Conclusions: Both the tests displayed similar sensitivity. However, the Aptima HPV assay was significantly more specific in the identification of women with CIN2+ disease in a colposcopy referral population.
- 3 October 2018
- Published by Wiley in Diagnostic Cytopathology
- Vol. 46 (12) , 987-992
Clinical performance of the Cobas 4800 HPV test and the Aptima HPV assay in the management of women referred to colposcopy with minor cytological abnormalities
Background: The aim of this study was to evaluate the clinical performance of the Cobas 4800 HPV test and the Aptima HPV assay for the detection of CIN2+ disease in women referred to colposcopy with minor cytological abnormalities.Methods: ThinPrep liquid‐based cytology samples were collected from 562 women referred to colposcopy with minor cytological abnormalities. HPV testing by both assays was performed on these samples. Clinical performances for detection of histologically diagnosed CIN2+ and CIN3+ were calculated.Results: HPV prevalence by the Cobas 4800 HPV test was 58.2% and 53.0% women tested positive with the Aptima HPV assay in the entire study population. The Aptima HPV assay and the Cobas 4800 HPV test displayed equivalent sensitivity of 90.2% (95%CI, 83.4‐94.9) for the detection of CIN2+ disease. However, the Aptima HPV assay displayed greater specificity of 61.0% (95% CI, 54.0‐68.0) when compared to the Cobas 4800 HPV test 53.0% (95% CI, 46.0‐60.0), and this was significantly higher (P = .0004). The Aptima HPV assay also displayed higher specificity 76.5% (95% CI, 66.0‐85.0) in the ASCUS category in comparison to the Cobas 4800 HPV test 65.0% (95% 54.0‐75.0) which was statistically significant (P = .004).Conclusions: Both the tests displayed similar sensitivity. However, the Aptima HPV assay was significantly more specific in the identification of women with CIN2+ disease in a colposcopy referral population.
- Open Access
- 19 July 2011
- Published by Wiley in British Journal of Haematology
- Vol. 156 (1) , 133-136
Genetic variation at the 8q24 locus confers risk to multiple myeloma
- 19 July 2011
- Published by Wiley in British Journal of Haematology
- Vol. 156 (1) , 133-136
Open AccessGenetic variation at the 8q24 locus confers risk to multiple myeloma
- 28 May 2009
- Published by American Society of Hematology in Blood
- Vol. 113 (22) , 5691-5692
Genetic variants in XRRC5 may predict development of venous thrombotic events in myeloma patients on thalidomide
To the editor: We read with great interest the recent findings by Johnson et al indicating that genetic variants in DNA repair genes, in particular XRCC5 , may play a crucial role in identifying myeloma patients on thalidomide treatment who are at high risk of acquiring treatment-related venous
- 28 May 2009
- Published by American Society of Hematology in Blood
- Vol. 113 (22) , 5691-5692
Genetic variants in XRRC5 may predict development of venous thrombotic events in myeloma patients on thalidomide
To the editor: We read with great interest the recent findings by Johnson et al indicating that genetic variants in DNA repair genes, in particular XRCC5 , may play a crucial role in identifying myeloma patients on thalidomide treatment who are at high risk of acquiring treatment-related venous
- Open Access
- 12 September 2007
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 16 (24) , 3117-3127
Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma
Cytogenetic analysis in myeloma reveals marked chromosomal instability. Both widespread genomic alterations and evidence of aberrant class switch recombination, the physiological process that regulates maturation of the antibody response, implicate the DNA repair pathway in disease pathogenesis. We therefore assessed 27 SNPs in three genes (XRCC3, XRCC4 and XRCC5) central to DNA repair in patients with myeloma and controls from the EpiLymph study and from an Irish hospital registry (n = 306 cases, 263 controls). For the haplotype-tagging SNP (htSNP) rs963248 in XRCC4, Allele A was significantly more frequent in cases than in controls (86.4 versus 80.8%; odds ratio 1.51; 95% confidence interval 1.10–2.08; P = 0.0133), as was the AA genotype (74 versus 65%) (P = 0.026). Haplotype analysis was performed using Unphased for rs963248 in combination with additional SNPs in XRCC4. The strongest evidence of association came from the A–T haplotype from rs963248–rs2891980 (P = 0.008). For XRCC5, the genotype GG from rs1051685 was detected in 10 cases from different national populations but in only one control (P = 0.015). This SNP is located in the 3′-UTR of XRCC5. Overall, these data provide support for the hypothesis that common variation in the genes encoding DNA repair proteins contributes to susceptibility to myeloma.
- 12 September 2007
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 16 (24) , 3117-3127
Open AccessVariation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma
Cytogenetic analysis in myeloma reveals marked chromosomal instability. Both widespread genomic alterations and evidence of aberrant class switch recombination, the physiological process that regulates maturation of the antibody response, implicate the DNA repair pathway in disease pathogenesis. We therefore assessed 27 SNPs in three genes (XRCC3, XRCC4 and XRCC5) central to DNA repair in patients with myeloma and controls from the EpiLymph study and from an Irish hospital registry (n = 306 cases, 263 controls). For the haplotype-tagging SNP (htSNP) rs963248 in XRCC4, Allele A was significantly more frequent in cases than in controls (86.4 versus 80.8%; odds ratio 1.51; 95% confidence interval 1.10–2.08; P = 0.0133), as was the AA genotype (74 versus 65%) (P = 0.026). Haplotype analysis was performed using Unphased for rs963248 in combination with additional SNPs in XRCC4. The strongest evidence of association came from the A–T haplotype from rs963248–rs2891980 (P = 0.008). For XRCC5, the genotype GG from rs1051685 was detected in 10 cases from different national populations but in only one control (P = 0.015). This SNP is located in the 3′-UTR of XRCC5. Overall, these data provide support for the hypothesis that common variation in the genes encoding DNA repair proteins contributes to susceptibility to myeloma.